Following a competitive open call, three new Proof-of-Concept (POC) research projects have been awarded to clinician-researcher teams affiliated with the Gulbenkian Institute for Molecular Medicine (GIMM), Unidade Local de Saúde Santa Maria (ULSSM) and Faculdade de Medicina da Universidade de Lisboa (FMUL) through the GIMM CARE clinical and translational research initiative.
Pedro Mota (ULSSM) and Luís Graça (GIMM, FMUL) will pilot the ambitious PRISM project, combining biomarkers with clinical information and predictive modelling to address an important unmet need in aneurysmal subarachnoid haemorrhage.
Through REMODEL-ID project, Marta Leal Bento (ULSSM, GIMM) and Yvonne Azasi (GIMM) will bring together hematology and infection biology to explore how therapies that modify red blood cell physiology may influence susceptibility to malaria.
Finally, the SPERMABILITY project team, consisting of Ana Aguiar (ULSSM, FMUL) and Paulo Navarro-Costa (FMUL) will pilot a new diagnostic and prognostic tool for male infertility.
Each project is awarded up to 50,000 EUR to deliver the project outcomes over the next eighteen months.
GIMM CARE is structured around broad long-term strategic missions aiming to boost clinical and translational research in Portugal. The next calls for Junior Clinician grants will open on 16th November 2026, with additional calls to come in 2027.
Find out more here.
